News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,121 Results
Type
Article (86466)
Company Profile (702)
Press Release (758953)
Multimedia
Podcasts (129)
Webinars (14)
Section
Business (232668)
Career Advice (4127)
Deals (39718)
Drug Delivery (129)
Drug Development (90981)
Employer Resources (198)
FDA (18102)
Job Trends (17332)
News (396436)
Policy (39744)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56827)
ALS (99)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (156)
Approvals (18068)
Artificial intelligence (325)
Autoimmune disease (29)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (481)
Bladder cancer (84)
Brain cancer (32)
Breast cancer (303)
Cancer (2432)
Cardiovascular disease (203)
Career advice (3534)
Career pathing (34)
CAR-T (172)
Cell therapy (489)
Cervical cancer (21)
Clinical research (73387)
Collaboration (910)
Compensation (543)
Complete response letters (30)
COVID-19 (2867)
CRISPR (48)
C-suite (264)
Cystic fibrosis (107)
Data (2261)
Decentralized trials (2)
Denatured (45)
Depression (55)
Diabetes (297)
Diagnostics (6919)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (127)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (96615)
Editorial (44)
Employer branding (25)
Employer resources (167)
Events (129966)
Executive appointments (772)
FDA (19420)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (815)
Gene editing (119)
Generative AI (35)
Gene therapy (357)
GLP-1 (851)
Government (5158)
Grass and pollen (6)
Guidances (59)
Healthcare (20886)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3028)
Inflammatory bowel disease (152)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (812)
IPO (17815)
IRA (51)
Job creations (5187)
Job search strategy (2861)
Kidney cancer (11)
Labor market (42)
Layoffs (555)
Leadership (24)
Legal (10113)
Liver cancer (81)
Lung cancer (345)
Lymphoma (158)
Machine learning (7)
Management (65)
Manufacturing (351)
MASH (74)
Medical device (14636)
Medtech (14641)
Mergers & acquisitions (22442)
Metabolic disorders (785)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2105)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Northern California (2736)
Now hiring (40)
Obesity (422)
Opinion (275)
Ovarian cancer (78)
Pain (97)
Pancreatic cancer (86)
Parkinson's disease (161)
Partnered (24)
Patents (250)
Patient recruitment (114)
Peanut (51)
People (65287)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22643)
Phase II (31858)
Phase III (24012)
Pipeline (1236)
Policy (170)
Postmarket research (3552)
Preclinical (10219)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (430)
Real estate (7392)
Recruiting (75)
Regulatory (26783)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (80)
Series A (142)
Series B (91)
Service/supplier (30)
Sickle cell disease (58)
Southern California (2370)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4291)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (44)
The Weekly (82)
United States (24648)
Vaccines (810)
Venture capitalists (44)
Weight loss (303)
Women's health (40)
Worklife (20)
Date
Today (153)
Last 7 days (924)
Last 30 days (2825)
Last 365 days (35919)
2025 (11660)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (268)
Arkansas (14)
Asia (50124)
Australia (8829)
California (6407)
Canada (2054)
China (560)
Colorado (283)
Connecticut (300)
Delaware (158)
Europe (114956)
Florida (936)
Georgia (219)
Hawaii (1)
Idaho (64)
Illinois (626)
India (31)
Indiana (331)
Iowa (12)
Japan (168)
Kansas (111)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (961)
Massachusetts (4922)
Michigan (246)
Minnesota (420)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (70)
New Jersey (1810)
New Mexico (31)
New York (1814)
North Carolina (1126)
North Dakota (9)
Northern California (2736)
Ohio (217)
Oklahoma (15)
Oregon (48)
Pennsylvania (1418)
Puerto Rico (13)
Rhode Island (36)
South America (1652)
South Carolina (23)
South Dakota (1)
Southern California (2370)
Tennessee (104)
Texas (962)
Utah (191)
Virginia (170)
Washington D.C. (69)
Washington State (604)
West Virginia (3)
Wisconsin (68)
There are 846,121 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breaking the Cycle: A New Approach to Treating Cardiac Fibrosis by Targeting Fibroblast Mechanosensing
May 1, 2025
·
1 min read
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
May 1, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development - Oncology
May 1, 2025
·
8 min read
Press Releases
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
May 1, 2025
·
14 min read
Press Releases
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
May 1, 2025
·
24 min read
Press Releases
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
May 1, 2025
·
1 min read
Press Releases
Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development
May 1, 2025
·
6 min read
Press Releases
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
May 1, 2025
·
2 min read
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
Announcing first-quarter results, Biogen CEO Chris Viehbacher admitted that tariffs are “a new topic for us,” but said he does not expect major impacts—at least for 2025.
May 1, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain
May 1, 2025
·
2 min read
1 of 84,613
Next
